166 related articles for article (PubMed ID: 37492434)
1. Assessing the urinary concentration of nitrofurantoin and its antibacterial activity against
Hung CC; Varga C; Reinhart JM; Maddox CW; Dilger RN; Forsythe L; Stevenson AK; Franklin-Guild RJ; Paul NC; Ramachandran A
Front Vet Sci; 2023; 10():1189374. PubMed ID: 37492434
[TBL] [Abstract][Full Text] [Related]
2. In vitro antimicrobial activity of nitrofurantoin against Escherichia coli and Staphylococcus pseudintermedius isolated from dogs and cats.
Maaland M; Guardabassi L
Vet Microbiol; 2011 Aug; 151(3-4):396-9. PubMed ID: 21482044
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic studies of nitrofurantoin against common uropathogens.
Komp Lindgren P; Klockars O; Malmberg C; Cars O
J Antimicrob Chemother; 2015 Apr; 70(4):1076-82. PubMed ID: 25515669
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial Resistance in Bacteria Causing Urinary Tract Infections.
Salh KK
Comb Chem High Throughput Screen; 2022; 25(7):1219-1229. PubMed ID: 34161207
[TBL] [Abstract][Full Text] [Related]
5. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA
Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of Nitrofurantoin and Fosfomycin Against Outpatient Urinary Isolates of Multidrug-Resistant Enterococci over a Period of 10 Years from India.
Das A; Banerjee T; Anupurba S
Microb Drug Resist; 2020 Dec; 26(12):1509-1515. PubMed ID: 31794690
[TBL] [Abstract][Full Text] [Related]
7. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H
Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
[TBL] [Abstract][Full Text] [Related]
8. Empirical treatment of lower urinary tract infections in the face of spreading multidrug resistance: in vitro study on the effectiveness of nitroxoline.
Sobke A; Makarewicz O; Baier M; Bär C; Pfister W; Gatermann SG; Pletz MW; Forstner C
Int J Antimicrob Agents; 2018 Feb; 51(2):213-220. PubMed ID: 29111434
[TBL] [Abstract][Full Text] [Related]
9. Nitrofurantoin plasma- and urine exposure in eight healthy beagle dogs following standard nitrofurantoin dosing regimen.
Ekstrand C; Michanek P; Salomonsson M; Tegner C; Pelander L
Res Vet Sci; 2022 Dec; 152():150-155. PubMed ID: 35973234
[TBL] [Abstract][Full Text] [Related]
10. Urinary antibacterial activity of fosfomycin and nitrofurantoin at registered dosages in healthy volunteers.
Wijma RA; Huttner A; van Dun S; Kloezen W; Abbott IJ; Muller AE; Koch BCP; Mouton JW
Int J Antimicrob Agents; 2019 Oct; 54(4):435-441. PubMed ID: 31382030
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo antibacterial activity of nitrofurantoin against clinical isolates of E. coli in Japan and evaluation of biological cost of nitrofurantoin resistant strains using a mouse urinary tract infection model.
Nakagawa S; Kurimoto Y; Ezumi M; Nakatani K; Mizunaga S; Yamagishi Y; Mikamo H
J Infect Chemother; 2021 Feb; 27(2):250-255. PubMed ID: 33060044
[TBL] [Abstract][Full Text] [Related]
12. Oral administration of an extended-release formulation of nitrofurantoin results in high concentrations in the urine of dogs.
Meyer EG; Bozynski C; Essel LB; Cohn L; Davis JL
J Am Vet Med Assoc; 2023 Aug; 261(8):1174-1180. PubMed ID: 37116876
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and antimicrobial susceptibility of Enterococcus spp. from urine of dogs and cats in northwestern Croatia.
Tumpa A; Štritof Z; Pintarić S
Res Vet Sci; 2022 Dec; 151():42-46. PubMed ID: 35853330
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial Resistance in Bacteria Isolated From Canine Urine Samples Submitted to a Veterinary Diagnostic Laboratory, Illinois, United States.
Yudhanto S; Hung CC; Maddox CW; Varga C
Front Vet Sci; 2022; 9():867784. PubMed ID: 35601398
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic and genotypic study of biofilm formation in Enterococci isolated from urinary tract infections.
Fallah F; Yousefi M; Pourmand MR; Hashemi A; Nazari Alam A; Afshar D
Microb Pathog; 2017 Jul; 108():85-90. PubMed ID: 28483600
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and pharmacodynamic evaluation of nitrofurantoin against Escherichia coli in a murine urinary tract infection model.
Maaland MG; Jakobsen L; Guardabassi L; Frimodt-Møller N
APMIS; 2024 Jul; 132(7):492-498. PubMed ID: 38558445
[TBL] [Abstract][Full Text] [Related]
17. Oral treatment options for patients with urinary tract infections caused by extended spectrum βeta-lactamase (ESBL) producing Enterobacteriaceae.
Raja NS
J Infect Public Health; 2019; 12(6):843-846. PubMed ID: 31176606
[TBL] [Abstract][Full Text] [Related]
18. The use of nitrofurantoin for children with acute cystitis caused by extended-spectrum Β-lactamase-producing Escherichia coli.
Kara A; Gurgoze MK
J Pediatr Urol; 2019 Aug; 15(4):378.e1-378.e5. PubMed ID: 31014984
[TBL] [Abstract][Full Text] [Related]
19. [Nitrofurantoin--clinical relevance in uncomplicated urinary tract infections].
Stock I
Med Monatsschr Pharm; 2014 Jul; 37(7):242-8. PubMed ID: 25065160
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of catheter-associated urinary tract infections and multi-drug-resistant Escherichia coli isolates from the urine of dogs with indwelling urinary catheters.
Ogeer-Gyles J; Mathews K; Weese JS; Prescott JF; Boerlin P
J Am Vet Med Assoc; 2006 Nov; 229(10):1584-90. PubMed ID: 17107313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
